New Alert: ACOL
Good morning members
, We found a play today that we think could be ready to run big.
ACOL has a lot of things going for it, but the biggest may just be its chart.
At just $0.0005 ACOL is bottom fishing at an all-time low...and ANY upward pressure can send it sky high.
We love these "cheap" sub penny plays. The gain potential is amazing.
ACOL has a lot going for it fundamentally too...
After November sales exceeded expectations, ACOL essentially experienced product shortages. ACOL is bullish on 2015 futures and sees the potential for strong earnings in the 1st Quarter.
This is a problem that many companies would love to have... so let’s look deeper to how and why ACOL’s product is becoming so popular. ACOL’s groundbreaking, patented product in the booming MJ market is known as the Medtainer:
- The Medtainer was nominated for the award of MJ “Product of the Year” and was sponsored by High Times Magazine at the 25th Annual Cannabis Cup in Amsterdam.
- The Company’s flagship product, the MedTainer was selected to be part of and placed in the Celebrity Bag Giveaway at this year’s American Music Awards.
- ACOL’s products are already found in more than 100 stores across the U.S.
- The Medtainer has recently been featured in major publications including Cannabis Now, Green Leaf, High Times and even the Weed Street Journal.
- Celebrities like Asher Roth and B-Real from Cypress Hill have been seen using the Medtainer product.
- GreenWave Advisors forecast that 37 states will pass MJ for medical purposes by 2020 and a dozen states will pass it for recreational use.
- Enormous growth of this market is also reflected in ACOL’s product sales: for the 6-month period ending June 30, 2014, the Company reported a Net Sales increase of 87%.
ACOL has a widely used and widely needed product in a booming market. It’s received high reviews, considerable accolades and an amazing level of pliability. As it’s slipped recently a bounce could translate to a big move, so let’s get to it:
According to their website, “Acology is bullish on 2015 futures and sees the potential for strong earnings in the 1st quarter.”
The Company’s 4th generation Medtainer is a patented, FDA approved #5 polypropylene container that is water-proof, smell-proof and child resistant. Its most impressive feature is a built-in grinder that has the ability to grinds pills, herbal medications, coffee beans and teas into fine powder.
ACOL also markets the Medtainer to the exploding MJ market, making it one of the hottest new MJ products around right now. It was nominated for product of the year by High Times, which is perhaps the biggest name in all of MJ.
The Company’s products can be found in more than 100 stores across the US and is beginning to receive a lot of attention, with the Medtainer being featured in major cannabis publications including 1000Watts, Nuggetry Magazine, Cannabis Now, Green Leaf, Hot Breath, HotBox Magazine, Cannabis Culture Magazine, and even the Weed Street Journal.
ACOL seems to be heavily in an all-out marketing mode right now as it is strategically building its advisory board with quality, well known industry professionals as well as respected professionals within the industries of which ACOL sees sales potential.
Recent news is a perfect example as ACOL announced the addition of the co-founder of the “Unconventional Foundation for Autism” to its team.
To keep up with demand ACOL has found it necessary to increase their manufacturing capabilities. As orders continue to surge the possibility of production shortfalls has forced ACOL to consider acquiring additional manufacturing equipment to deal with the increasing demand.
Do I have your attention yet?
Tonight’s play could be the whole package. From product to company to market… ACOL has a lot going their way right now.
The recent elections saw Oregon, Alaska and Washington D.C. all pass their initiatives in favor of MJ. I’m sure you remember the market boom when Colorado & Washington voted to pass recreational MJ. Some MJ companies saw enormous gains the likes of which are rarely seen.
In fact, I recently read this article that was released by Forbes: Why Legalizing Medical Marijuana Will Make Investors Extremely Wealthy
With the MJ market expected to grow 64% to 2.34Bln in 2014 up from 1.44Bln the previous year, the potential for professional companies to help legitimize the industry and to draw profits from it appears to be on the horizon.
The Medtainer:
The Medtainer is the first-ever polypropylene airtight, watertight, smell-proof delivery and storage container that has a built in grinder. Take a look at the Product on the Company’s website:
http://themedtainer.myshopify.com/collections
The Medtainer is manufactured from medical-grade No. 5 polypropylene resin that is non-porous and non-leaching. The Medtainer is composed of FDA approved medical grade plastics and is environmentally safe.
These containers are portable and affordable and give consumers the ability to easily store, carry and grind herbs and herbal remedies, teas, medicines, and other solids or liquids without cross-contamination or leakage.
Target markets include Private & Compounding Pharmacies, Oriental and Traditional Herbal Pharmacists, and Veterinary Clinicians. The following quote discussing future growth was taken straight out of their press release:
“Acology marketing and sales efforts are now focusing on these markets and increasing revenue is expected as distribution climbs in 2014.”
For the six-month period ending June 30, 2014, ACOL reported a Net Sales increase of 87%, or $168k as compared to $90k for the six-month period ended June 30, 2013.
Recent Developments:
ACOL recently completed its new headquarters and manufacturing facility located in Corona, CA. Key benefits include the expanded manufacturing capabilities and shipping areas, allowing for increased volume and efficiency.
ACOL entered an agreement with Specialty Pharmacy, a dispensing chemists compounding pharmacy, to provide the Medtainer for its customers.
The Company has also announced they are in serious talks with Altura Pharmaceuticals to provide the Medtainer to Altura's pharmacies in all 8 states that it has a presence in. Primo Cabral, the President of Altura Pharmaceuticals, stated:
"We found the Medtainer extremely effective in reducing pills, and especially hard pills, to a fine powder in just a matter of seconds. This reduces the need to use more traditional methods, such as a mortar and pestle, saving time and energy."
ACOL has a very unique and patented product that is servicing the MedMJ market and even has several celebrities already using it in public. As the Medtainer gains traction and more and more celebs are seen with it, ACOL should continue its rise to fame.
As I stated earlier, ACOL could be the “Real Deal”. From product - to company - to market… ACOL has a lot going their way right now.
We could be looking at a one-of-a-kind situation unfolding right before our very eyes.
The Editor
Massivestockprofits.com
Disclaimer
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. MassiveStockProfits.com employees are not registered as an Investment Adviser in any jurisdiction whatsoever.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead MassiveStockProfits.com strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. MassiveStockProfits.com does not offer such advice or analysis, and MassiveStockProfits.com further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries and extremely high degree of risk. It is possible that an investor's investment may be lost or impaired due to the speculative nature of the companies profiled.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be "forward looking statements". Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as "projects", "foresee", "expects", "will", "anticipates", "estimates", "believes", "understands", or that by statements indicating certain actions "may", "could", or "might" occur. Understand there is no guarantee past performance will be indicative of future results.
In preparing this publication, MassiveStockProfits.comhas relied upon information supplied by its customers, and press releases which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this website. Rather, investors should use the information contained in this website as a starting point for doing additional independent research on the featured companies. The advertisements in this website are believed to be reliable, however, MassiveStockProfits.com and its owners, affiliates, subsidiaries, officers, directors, representatives and agents disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of materials facts from such advertisement. MassiveStockProfits.comis not responsible for any claims made by the companies advertised herein. MassiveStockProfits.com has been compensated up to one thousand dollars for this profile of ACOL by a non related third party.
MassiveStockProfits.com may receive compensation and its employees and affiliates may own stock that they have purchased in the open market either prior, during, or after the release of the companies profile which is an inherent conflict of interest in MassiveStockProfits.com statements and opinions and such statements and opinions cannot be considered independent. MassiveStockProfits.com and its management may benefit from any increase in the share price of the profiled companies and hold the right to sell the shares bought at any given time including shortly after the release of the companies profile. Any and all compensation received in cash will always be disclosed below.
MassiveStockProfits.com may on occasion accept compensation in free-trading shares for it's marketing services of the company being profiled, and the third party that might have compensated MassiveStockProfits.com may hold free-trading shares of the company being profiled and could very well be selling shares of the companies stock at the same time the profile is being disseminated to potential investors; this should be viewed as a definite conflict of interest and as such, the reader should take this into consideration. If MassiveStockProfits.com never accepts compensation in the form of free trading shares of the company being profiled and decides to sell these shares into the public market at any time before, during, or after the release of the companies profile our disclaimer will be updated accordingly reflecting the current position of those free trading shares received as compensation for our services.
